| Literature DB >> 23917785 |
Abstract
89Sr is useful for the palliation of painful bone metastasis, but its antitumor activity as a monotherapy has not been shown by 18F-FDG PET. Here, we report a case of a 75-year-old woman with multiple bone metastases of breast cancer in which 18F-FDG PET demonstrated a significant reduction in uptake of 18F-FDG after administration of 89Sr.Entities:
Mesh：
Substances：
Year: 2014 PMID： 23917785 DOI： 10.1097/RLU.0b013e318292f35c
Source DB: PubMed Journal: Clin Nucl Med ISSN： 0363-9762 Impact factor: 7.794